Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

GOODWILL AND INTANGIBLE ASSETS, NET (Narrative) (Details)

v3.23.1
GOODWILL AND INTANGIBLE ASSETS, NET (Narrative) (Details) - CAD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of subsidiaries [line items]      
Amortization expense $ 2,343 $ 1,158 $ 31
Goodwill 9,771 121,303  
Amortization expenses from continuing operations 1,302    
Amortization expenses from discontinued operations $ 1,041    
Adjupharm GmbH ("Adjupharm") [Member]      
Disclosure of subsidiaries [line items]      
Goodwill impairment   275  
Trichome Financial Corp. (“Trichome”) [Member]      
Disclosure of subsidiaries [line items]      
Pre-tax discount rate of cash flows 17.50%    
Fixed growth rate 2.00%    
Goodwill $ 107,854    
Intangible assets impairment   $ 3,067